BoxGroup
 | |
| Company type | Privately held company |
|---|---|
| Industry | Venture capital and private equity |
| Founded | 2007 in New York City, United States |
| Headquarters | , United States |
Area served | United States and Europe |
Key people |
|
| Services | Seed funding |
| Website | boxgroup |
BoxGroup is an investment fund company based in New York City.[1] The company was founded in 2007 by David Tisch, grandson of entrepreneurs Laurence A. Tisch, and Adam Rothenberg.[2]
BoxGroup invests in the pre-seed and seed rounds of financing for early-stage companies. One of the financing companies they have invested in, is Ramp, a corporate card start-up. [3] The venture capital fund invests in start-up technology businesses in many sectors including marketplaces, e-commerce, SAAS, and financial tech.[1][4][5]
BoxGroup was among the top three most active United States–based micro venture capital firms in 2014.[6] The company was listed in Poet & Quants "Top 20 Investors Behind MBA Startups" and has more than 230 investments startup companies including Vine, Groupme, Warby Parker and Behance.[7][2][8][9]
References
[edit]- ^ a b Nicolette Tuono (February 18, 2014). "A New York VC Spotlight: Adam Rothenberg". Alley Watch. Retrieved March 7, 2016.
- ^ a b Nathan Allen (March 2, 2015). "The top 20 investors behind MBA startups". Poets & Quants. Retrieved March 7, 2016.
- ^ "Ramp, a Brex and Amex rival, raises $25 million for a new corporate card". Fortune. Retrieved 2020-02-21.
- ^ "Jessica Kreps, Adam Rothenberg". The New York Times. October 27, 2013. Retrieved March 7, 2016.
- ^ "Investability of a startup: Interview with BoxGroup's David Tisch". Under 30 CEO. 2016. Retrieved March 7, 2016.
- ^ Tanya Benedicto Klich (February 19, 2015). "VC 100: The top investors in early-stage startups". Entrepreneur. Retrieved March 7, 2016.
- ^ "How the quiet Adam Rothenberg become number two at hot startup incubator, TechStars NY". Venture Beat. March 12, 2012. Retrieved March 7, 2016.
- ^ Keenan, Joseph (30 November 2022). "Vial reels in $67M in series B fund raising; adds NEXT Oncology to network". Fierce Biotech.
- ^ Gormley, Brian (30 November 2022). "General Catalyst Backs Clinical Trials Startup Vial". Wall Street Journal.
  | This article about a private equity or venture capital firm is a stub. You can help Wikipedia by expanding it. |